Showing results (1321-1330 of 1,512) with videos related to
Sort By:
Pageof 152
Lung Cancer (Amsterdam, Netherlands)|March 3, 2024
Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201Byoung Chul Cho, Ji-Youn Han, Ki Hyeong Lee, et al.Surgical Endoscopy|July 13, 2021
The impact of preoperative EUS-FNA for distal resectable pancreatic cancer: Is it really effective enough to take risks?Jin-Seok Park, Jae Hoon Lee, Tae Jun Song, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 11, 2021
Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKDChanghyun Lee, Jung Tak Park, Tae-Ik Chang, et al.The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|December 4, 2003
[A case of eosinophilic pancreatitis]Jin Woo Song, Myung Hwan Kim, Wook Jang Seo, et al.Cancer Chemotherapy and Pharmacology|June 10, 2017
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patientsBum Jun Kim, Jaewon Hyung, Changhoon Yoo, et al.Lung Cancer (Amsterdam, Netherlands)|November 27, 2007
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancerKyung-Hun Lee, Hye Sook Min, Sae-Won Han, et al.Journal of Korean Medical Science|February 6, 2009
Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin A nephropathy in Korean patientsHyung Jin Yoon, Ho Jun Chin, Ki Young Na, et al.Journal of Cancer Research and Clinical Oncology|July 1, 2011
Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapyBhumsuk Keam, Seock-Ah Im, Sohee Park, et al.Journal of Cancer Research and Clinical Oncology|May 6, 2014
Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosisYu Jung Kim, Su-Jung Kim, June Koo Lee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2017
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung CancerEnriqueta Felip, Fabrice Barlesi, Benjamin Besse, et al.Pageof 152